Dr. James Rothman
InvestorSenior Advisor at Celesta Capital
About
Dr. James Rothman is a biomedical researcher who joined Celesta Capital as a Senior Advisor supporting the firm's bio-convergence strategy. He received the 2013 Nobel Prize in Physiology or Medicine for discoveries on the transfer of materials among cells, and serves as Chairman of the Yale School of Medicine's Department of Cell Biology and Director of Yale's Nanobiology Institute. His prior roles include Chief Scientist of General Electric Healthcare and faculty positions at Stanford, Princeton, Columbia, and Memorial Sloan-Kettering Cancer Center.
Invests in
BiotechDeep TechHealthtech
Colleagues at Celesta Capital
Anand Chandrasekaran
Managing Partner at Celesta Capital
Anita Rehman
Partner at Celesta Capital
.avif)
Arun Kumar
Managing Partner at Celesta Capital
Charles Lespérance
Partner at Celesta Capital
David Goldman
Partner at Celesta Capital
Dr. Arogyaswami Paulraj
Senior Advisor at Celesta Capital
Frantz Saintellemy
Senior Advisor at Celesta Capital
.webp)
Jonathan Kaplan
Senior Advisor at Celesta Capital
Frequently asked questions
- Where does Dr. James Rothman work?
- Dr. James Rothman is Senior Advisor at Celesta Capital.
- What does Dr. James Rothman invest in?
- Dr. James Rothman invests in Biotech, Deep Tech, Healthtech.